首页> 外国专利> COMPOSITION FOR CANCER PREVENTION OR TREATMENT CONTAINING AS ACTIVE INGREDIENT PLANT STEM CELL LINE DERIVED FROM CAMBIUM OF PANAX GINSENG INCLUDING WILD GINSENG OR GINSENG

COMPOSITION FOR CANCER PREVENTION OR TREATMENT CONTAINING AS ACTIVE INGREDIENT PLANT STEM CELL LINE DERIVED FROM CAMBIUM OF PANAX GINSENG INCLUDING WILD GINSENG OR GINSENG

机译:以人参(包括人参或人参)为基础的人参活性成分为活性成分植物干细胞系的癌症预防或治疗组合物

摘要

The present invention relates to a composition for preventing or treating cancer, which contains, as an active ingredient, a Panax ginseng cambium-derived cell line including wild ginseng or ginseng; a lysate thereof; an extract thereof; or a culture medium thereof. The cell line according to the present invention, a lysate thereof, an extract thereof and a culture medium thereof are derived from a natural and have minimized side effects compared to the conventional therapeutic drugs, and thus are safe for the human body. Also, they are involved directly in the growth of cancer to induce cancer cell death effectively, and show anticancer activity of inhibiting or reducing the formation of tumor or the growth of tumor, Accordingly, the cell line, the lysate thereof, the extract thereof and the culture medium thereof are useful for the prevention, treatment and alleviation of cancer.
机译:本发明涉及一种用于预防或治疗癌症的组合物,其包含作为活性成分的人参人参形成层衍生的细胞系,其包括野生人参或人参。其裂解物;其提取物;或其培养基。与常规治疗药物相比,根据本发明的细胞系,其裂解物,其提取物和其培养基源自天然并且具有最小的副作用,因此对于人体是安全的。而且,它们直接参与癌症的生长以有效诱导癌细胞死亡,并显示出抑制或减少肿瘤形成或肿瘤生长的抗癌活性,因此,它们的细胞系,其裂解物,其提取物和其培养基可用于预防,治疗和减轻癌症。

著录项

  • 公开/公告号EP2353603A4

    专利类型

  • 公开/公告日2012-08-01

    原文格式PDF

  • 申请/专利权人 UNHWA CORPORATION;

    申请/专利号EP20090824997

  • 发明设计人 JIN YOUNG WOO;LEE EUN KYONG;

    申请日2009-11-06

  • 分类号A61K36/258;A23L1/30;A61P35;C12N5/04;

  • 国家 EP

  • 入库时间 2022-08-21 17:15:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号